CTC (Chicago Trading Company)’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-709
Closed -$340K 330
2023
Q4
$340K Sell
709
-839
-54% -$5.14K ﹤0.01% 303
2023
Q3
$1.12M Sell
1,548
-1,059
-41% -$8.46K ﹤0.01% 317
2023
Q2
$1.94M Sell
2,607
-4,705
-64% -$37K ﹤0.01% 284
2023
Q1
$4.82M Sell
7,312
-941
-11% -$8.66K ﹤0.01% 281
2022
Q4
$8.46M Buy
8,253
+4,579
+125% +$80.8K 0.01% 241
2022
Q3
$6.65M Sell
3,674
-677
-16% -$29.3K ﹤0.01% 249
2022
Q2
$22.3M Buy
4,351
+260
+6% +$13.5K 0.01% 197
2022
Q1
$30.1M Buy
4,091
+1,219
+42% +$109K 0.01% 188
2021
Q4
$41M Buy
2,872
+817
+40% +$140K 0.02% 115
2021
Q3
$42.6M Buy
+2,055
New +$453K 0.02% 87

Other funds holding NVAX

CTC (Chicago Trading Company)'s NVAX Position: Q2 2022 in Review

CTC (Chicago Trading Company) sold out of Novavax (NVAX) in Q2 2022, closing a stake of 10,983 shares — an estimated $569K sold.

CTC (Chicago Trading Company) first reported a position in NVAX in Q3 2021 and held it in 3 quarters. The position peaked at $37.1M in Q3 2021. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • CTC (Chicago Trading Company) reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 10,983 Novavax shares in Q2 2022, an estimated $569K.
  • CTC (Chicago Trading Company) first reported a position in Novavax in Q3 2021 and held it in 3 quarters.
  • CTC (Chicago Trading Company)'s Novavax position peaked at $37.1M in Q3 2021.
  • 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on CTC (Chicago Trading Company)'s 13F filing for Q2 2022, filed 7 Jul 2022.